Hakutulokset - Karl Kieburtz

Tarkenna hakua
  1. 1
    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease

    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease Tekijä Karl Kieburtz

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    The relationship between uric acid levels and Huntington's disease progression

    The relationship between uric acid levels and Huntington's disease progression Tekijä Peggy Auinger, Karl Kieburtz, Michael McDermott

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    A review of disease progression models of Parkinson's disease and applications in clinical trials

    A review of disease progression models of Parkinson's disease and applications in clinical trials Tekijä Charles S. Venuto, Nicholas B. Potter, E. Ray Dorsey, Karl Kieburtz

    Julkaistu 2016
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    The relationship between CAG repeat length and clinical progression in Huntington's disease

    The relationship between CAG repeat length and clinical progression in Huntington's disease Tekijä Bernard Ravina, Megan Romer, Radu Constantinescu, Kevin Biglan, Alicia Brocht, Karl Kieburtz, Ira Shoulson, Michael McDermott

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Levodopa and the Progression of Parkinson's Disease

    Levodopa and the Progression of Parkinson's Disease Tekijä Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph, Anthony E. Lang, C. Warren Olanow, Caroline M. Tanner, Kenneth Marek

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Moving Parkinson care to the home

    Moving Parkinson care to the home Tekijä E. Ray Dorsey, Floris P. Vlaanderen, Lucien JLPG Engelen, Karl Kieburtz, William Zhu, Kevin Biglan, Marjan J. Faber, Bastiaan R. Bloem

    Julkaistu 2016
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Prevalence of dementia in rural China: impact of age, gender and education

    Prevalence of dementia in rural China: impact of age, gender and education Tekijä Dao Zhou, Ching‐Fen Wu, Haitao Qi, Jin‐Hu Fan, X. D. Sun, Peter G. Como, You‐Lin Qiao, Lu Zhang, Karl Kieburtz

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Trinucleotide repeat length and progression of illness in Huntington's disease.

    Trinucleotide repeat length and progression of illness in Huntington's disease. Tekijä Karl Kieburtz, Marcy E. MacDonald, Chiu-Yang Shih, Andrew Feigin, Kim Steinberg, Kathy Bordwell, Carol Zimmerman, Jayalakshmi Srinidhi, Jenny Sotack, James F. Gusella

    Julkaistu 1994
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort Tekijä Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Daniel Weintraub, Brit Mollenhauer, Shirley Lasch, Caroline M. Tanner, Danna Jennings, Karl Kieburtz, Lana M. Chahine, Kenneth Marek

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial Tekijä Deborah I. Friedman, Michael McDermott, Karl Kieburtz, Mark J. Kupersmith, Ann Stoutenburg, John L. Keltner, Steven E. Feldon, Eleanor Schron, James J. Corbett, Michael Wall

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial Tekijä Michael Wall, Mark J. Kupersmith, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Michael McDermott

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss

    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss Tekijä Michael Wall, Michael McDermott, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Mark J. Kupersmith

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Results of the citalopram to enhance cognition in Huntington disease trial

    Results of the citalopram to enhance cognition in Huntington disease trial Tekijä Leigh J. Beglinger, William Adams, Douglas R. Langbehn, Jess G. Fiedorowicz, Ricardo E. Jorge, Kevin Biglan, John N. Caviness, Blair Olson, Robert G. Robinson, Karl Kieburtz, Jane S. Paulsen

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease Tekijä Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease Tekijä Rachelle S. Doody, Rema Raman, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G. Thomas, Paul Aisen, Eric Siemers, Gopalan Sethuraman, Richard C. Mohs

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease

    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease Tekijä Peter A. LeWitt, Robert A. Hauser, Donald G. Grosset, Fabrizio Stocchi, Marie Saint‐Hilaire, Aaron Ellenbogen, Mika Leinonen, Neil B. Hampson, Tia DeFeo-Fraulini, Martin I. Freed, Karl Kieburtz

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Trichloroethylene: An Invisible Cause of Parkinson’s Disease?

    Trichloroethylene: An Invisible Cause of Parkinson’s Disease? Tekijä E. Ray Dorsey, Maryam Zafar, Samantha E. Lettenberger, Meghan Pawlik, Dan Kinel, Myrthe Frissen, Ruth B. Schneider, Karl Kieburtz, Caroline M. Tanner, Briana R. De Miranda, Samuel M. Goldman, Bastiaan R. Bloem

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    HIV-associated cognitive impairment before and after the advent of combination therapy

    HIV-associated cognitive impairment before and after the advent of combination therapy Tekijä Ned Sacktor, Michael McDermott, Karen Marder, Giovanni Schifitto, Ola A. Selnes, Justin C. McArthur, Yaakov Stern, Steven M. Albert, Donna Palumbo, Karl Kieburtz, Joy Antonelle de Marcaida, Bruce A. Cohen, Leon G. Epstein

    Julkaistu 2002
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study Tekijä C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia

    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia Tekijä Jeffrey Sevigny, Steven M. Albert, Michael McDermott, Justin C. McArthur, Ned Sacktor, Kathy Conant, Giovanni Schifitto, Ola A. Selnes, Yaakov Stern, Daniel McClernon, Donna Palumbo, Karl Kieburtz, Garrett Riggs, Bevin Cohen, Leon G. Epstein, Karen Marder

    Julkaistu 2004
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: